These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32425775)

  • 1. Pharmacological Interventions for Bacterial Prostatitis.
    Xiong S; Liu X; Deng W; Zhou Z; Li Y; Tu Y; Chen L; Wang G; Fu B
    Front Pharmacol; 2020; 11():504. PubMed ID: 32425775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefoxitin-based antibiotic therapy for extended-spectrum β-lactamase-producing Enterobacteriaceae prostatitis: a prospective pilot study.
    Demonchy E; Courjon J; Ughetto E; Durand M; Risso K; Garraffo R; Roger PM
    Int J Antimicrob Agents; 2018 Jun; 51(6):836-841. PubMed ID: 29378342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant
    Zhanel GG; Zhanel MA; Karlowsky JA
    Can J Infect Dis Med Microbiol; 2018; 2018():1404813. PubMed ID: 29666664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent extended-spectrum β-lactamase-positive Escherichia coli chronic prostatitis successfully treated with a combination of fosfomycin and doxycycline.
    Cunha BA; Gran A; Raza M
    Int J Antimicrob Agents; 2015 Apr; 45(4):427-9. PubMed ID: 25662814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Fosfomycin Formulation in Bacterial Prostatitis: New Role for an Old Molecule-Brief Literature Review and Clinical Considerations.
    Marino A; Stracquadanio S; Bellanca CM; Augello E; Ceccarelli M; Cantarella G; Bernardini R; Nunnari G; Cacopardo B
    Infect Dis Rep; 2022 Aug; 14(4):621-634. PubMed ID: 36005269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic prostatitis caused by extended-spectrum β-lactamase-producing
    Almeida F; Santos Silva A; Silva Pinto A; Sarmento A
    IDCases; 2019; 15():e00493. PubMed ID: 30766796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive overview of prostatitis.
    Khan FU; Ihsan AU; Khan HU; Jana R; Wazir J; Khongorzul P; Waqar M; Zhou X
    Biomed Pharmacother; 2017 Oct; 94():1064-1076. PubMed ID: 28813783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biofilms in chronic bacterial prostatitis (NIH-II) and in prostatic calcifications.
    Mazzoli S
    FEMS Immunol Med Microbiol; 2010 Aug; 59(3):337-44. PubMed ID: 20298500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current challenges in the treatment of complicated urinary tract infections and prostatitis.
    Wagenlehner FM; Naber KG
    Clin Microbiol Infect; 2006 May; 12 Suppl 3():67-80. PubMed ID: 16669930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of acute prostatitis caused by extended-spectrum beta-lactamase-producing Escherichia coli after transrectal prostate biopsy.
    Ozden E; Bostanci Y; Yakupoglu KY; Akdeniz E; Yilmaz AF; Tulek N; Sarikaya S
    Urology; 2009 Jul; 74(1):119-23. PubMed ID: 19464043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fosfomycin: past, present and future].
    Baylan O
    Mikrobiyol Bul; 2010 Apr; 44(2):311-21. PubMed ID: 20549968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and microbiological characteristics of spontaneous acute prostatitis and transrectal prostate biopsy-related acute prostatitis: Is transrectal prostate biopsy-related acute prostatitis a distinct acute prostatitis category?
    Kim JW; Oh MM; Bae JH; Kang SH; Park HS; Moon du G
    J Infect Chemother; 2015 Jun; 21(6):434-7. PubMed ID: 25701308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral fosfomycin for the treatment of chronic bacterial prostatitis.
    Karaiskos I; Galani L; Sakka V; Gkoufa A; Sopilidis O; Chalikopoulos D; Alivizatos G; Giamarellou E
    J Antimicrob Chemother; 2019 May; 74(5):1430-1437. PubMed ID: 30796442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and management of extended-spectrum beta-lactamase and quinolone-resistant Escherichia coli infections after prostate biopsy.
    Song W; Choo SH; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee KS; Lee SW; Lee HM; Choi HY; Jeon HG
    Urology; 2014 Nov; 84(5):1001-7. PubMed ID: 25443894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea.
    Lee Y; Lee DG; Lee SH; Yoo KH
    J Korean Med Sci; 2016 Nov; 31(11):1808-1813. PubMed ID: 27709861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is fosfomycin a potential treatment alternative for multidrug-resistant gram-negative prostatitis?
    Gardiner BJ; Mahony AA; Ellis AG; Lawrentschuk N; Bolton DM; Zeglinski PT; Frauman AG; Grayson ML
    Clin Infect Dis; 2014 Feb; 58(4):e101-5. PubMed ID: 24170195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The perspectives of the application of phage therapy in chronic bacterial prostatitis.
    Letkiewicz S; Międzybrodzki R; Kłak M; Jończyk E; Weber-Dąbrowska B; Górski A
    FEMS Immunol Med Microbiol; 2010 Nov; 60(2):99-112. PubMed ID: 20698884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis.
    Los-Arcos I; Pigrau C; Rodríguez-Pardo D; Fernández-Hidalgo N; Andreu A; Larrosa N; Almirante B
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1854-8. PubMed ID: 26666924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of selective media for detecting fluoroquinolone-insusceptible/extended-spectrum beta-lactamase-producing Escherichia coli before transrectal prostate biopsy.
    Sadahira T; Wada K; Araki M; Ishii A; Watanabe T; Nasu Y; Tsugawa M; Takenaka T; Nasu Y; Kumon H
    Int J Urol; 2017 Dec; 24(12):842-847. PubMed ID: 28929546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.